Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report 2024

Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2024 – By Type (RNA Interference (RNAi), RNA Antisense), By Technology (Enabling Technology, Enabled Technology), By Therapeutic Area (Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas), By End User (Research Institutes, Hospitals And Clinics ) – Market Size, Trends, And Global Forecast 2024-2033

Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Definition

The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways.

The main types of ribose-nucleic acid (RNA)-based therapeutics are RNA interference (RNAi) and RNA antisense. RNA interference (RNAi) is a biological process where RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. The various technologies include enabling technology. It is used for varying therapeutic areas such as oncology, genetic disorders, ophthalmology, hematological disorders, acute hepatic porphyria (AHP), and others by different end users, including research institutes, hospitals, and clinics.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segmentation

The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented –

1) By Type: RNA Interference (RNAi), RNA Antisense

2) By Technology: Enabling Technology, Enabled Technology

3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas

4) By End User: Research Institutes, Hospitals And Clinics

Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size 2023 to 2028: Graph

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size 2024 And Growth Rate

The ribose-nucleic acid (RNA)-based therapeutics market size has grown strongly in recent years. It will grow from $14.54 billion in 2023 to $15.79 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to investment and funding growth, the discovery of RNA interference (RNAi), clinical successes of antisense oligonucleotides (ASOs), regulatory support and frameworks, and collaborations, and partnerships.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Forecast

The ribose-nucleic acid (RNA)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to $22.30 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Major trends in the forecast period include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization and market growth.

Book your 30 minutes free consultation with our research experts

Contact Us

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Driver: Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market

The increasing prevalence of cancer is expected to propel the growth of the ribose-nucleic acid (RNA)-based therapeutics market going forward. Cancer refers to a condition where abnormal cells grow and spread uncontrollably, potentially leading to death if untreated. The prevalence of cancer is due to an aging population, lifestyle changes, greater exposure to risks, and better detection methods. RNA-based therapeutics offer a promising avenue for cancer treatment by directly targeting the genetic and molecular mechanisms of cancer. For instance, in August 2023, according to the Australian Institute of Health and Welfare, an Australia-based government administration for health, around 151,000 individuals were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, which is expected to reach 185,000 in 2030. Therefore, the increasing prevalence of cancer is driving the ribose-nucleic acid (RNA)-based therapeutics market.

Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Major Players

Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics

Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Trend: Advancements In RNA-Based Therapeutics With mRNA-Based Vaccines

Major companies operating in the ribose nucleic acid (RNA)-based therapeutics market are focused on developing innovative medication solutions, such as messenger RNA (mRNA)-based booster vaccines, to enhance the effectiveness of immunization, address emerging viral variants, and improve the overall durability of vaccine-induced immunity. An mRNA-based booster vaccine uses messenger RNA to prompt cells to create a protein that enhances the body's immune response against a particular pathogen. For instance, in June 2023, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical company, launched GEMCOVAC-OM, a India's first mRNA booster vaccine specifically targeting the Omicron variant of COVID-19. This booster is essential due to the limited efficacy of the original vaccines against Omicron. Utilizing mRNA technology, GEMCOVAC-OM boosts immunity and offers enhanced protection against the evolving virus.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Merger And Acquisition: Orna Therapeutics Acquired ReNAgade Therapeutics To Enhance RNA-Based Therapeutics Capabilities

In May 2024, Orna Therapeutics, a US-based biotechnology company focusing on developing RNA-based therapeutics, acquired ReNAgade Therapeutics for an undisclosed amount. Through this acquisition, Orna seeks to enhance its industry-leading strategy by merging its circular RNA expression technology with ReNAgade's extensive LNP-based RNA delivery systems and editing programs. ReNAgade Therapeutics is a US-based biotechnology company specializing in RNA-based therapeutics.

Regional Outlook For The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2023. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribose-nucleic acid (RNA)-based therapeutics market consists of revenues earned by entities by custom synthesis of RNA, RNA delivery systems, and RNA sequencing analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribose-nucleic acid (RNA)-based therapeutics market also include the sale of microRNA (miRNA) therapeutics, antisense oligonucleotides, and messenger RNA (mRNA) vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The ribose-nucleic acid (RNA)-based therapeutics market research report is one of a series of new reports from The Business Research Company that provides ribose-nucleic acid (RNA)-based therapeutics market statistics, including ribose-nucleic acid (RNA)-based therapeutics industry global market size, regional shares, competitors with a ribose-nucleic acid (RNA)-based therapeutics market share, detailed ribose-nucleic acid (RNA)-based therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the ribose-nucleic acid (RNA)-based therapeutics industry. This ribose-nucleic acid (RNA)-based therapeutics market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $15.79 billion
Revenue Forecast In 2033 $22.30 billion
Growth Rate CAGR of 9.0% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Characteristics

    3. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Trends And Strategies

    4. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size and Growth

    5.1. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segmentation

    6.1. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    RNA Interference (RNAi)

    RNA Antisense

    6.2. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Enabling Technology

    Enabled Technology

    6.3. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Genetic Disorder

    Ophthalmology

    Hematological Disorders

    Acute Hepatic Porphyria (AHP)

    Other Therapeutic Areas

    6.4. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Research Institutes

    Hospitals And Clinics

    7. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Regional And Country Analysis

    7.1. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    8.1. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    9.1. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    9.2. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    10.1. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    11.1. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    11.2. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    12.1. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    13.1. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    14.1. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    14.2. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    15.1. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    15.2. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    16.1. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    17.1. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    18.1. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    19.1. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    20.1. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    21.1. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    21.2. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    22.1. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    23.1. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    23.2. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    24.1. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    24.2. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    25.1. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    25.2. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    26.1. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    26.2. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    27.1. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    28.1. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    28.2. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    29.1. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

    29.2. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Landscape

    30.2. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Eli Lilly and Company

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novo Nordisk A/S

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Regeneron Pharmaceuticals

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Biogen Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Other Major And Innovative Companies

    31.1. Houston Methodist Hospital

    31.2. BioNTech

    31.3. University of Oxford

    31.4. Alnylam Pharmaceuticals

    31.5. Sarepta Therapeutics

    31.6. Flagship Pioneering

    31.7. Ionis Pharmaceuticals

    31.8. Akcea Therapeutics Inc

    31.9. Arrowhead Pharmaceuticals

    31.10. Dicerna Pharmaceuticals

    31.11. Wave Life Sciences

    31.12. Pharmaceutical Technology

    31.13. Quark Pharmaceuticals

    31.14. Tekmira Pharmaceuticals

    31.15. ReCode Therapeutics

    32. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Benchmarking

    33. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

    35. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Future Outlook and Potential Analysis

    35.1 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: F. Hoffmann-La Roche AG Financial Performance
  • Table 76: Eli Lilly and Company Financial Performance
  • Table 77: Novo Nordisk A/S Financial Performance
  • Table 78: Regeneron Pharmaceuticals Financial Performance
  • Table 79: Biogen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: F. Hoffmann-La Roche AG Financial Performance
  • Figure 76: Eli Lilly and Company Financial Performance
  • Figure 77: Novo Nordisk A/S Financial Performance
  • Figure 78: Regeneron Pharmaceuticals Financial Performance
  • Figure 79: Biogen Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Read More

Nucleic Acid Isolation & Purification Global Market Report 2024 – By Type( Plasmid DNA Isolation and Purification, Total RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, Genomic DNA Isolation and Purification, Messenger RNA Isolation and Purification, microRNA Isolation and Purification, PCR Cleanup, Other Nucleic Acid Isolation and Purification Types), By Method( Column-based Isolation and Purification, Magnetic Bead-based Isolation and Purification, Reagent-based Isolation and Purification, Other Isolation and Purification Methods), By Application, By End-user – Market Size, Trends, And Global Forecast 2024-2033

View Report

Automated Nucleic Acid Extraction Devices Global Market Report 2024 – By Type (Instruments, Kits, Consumables), By Product (Fully Automated, Semi-Automated), By End User (Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024 – By Type (Capping Agents, Nucleotides, Plasmid DNA, Other Types), By Applications (Therapeutics Production, Vaccine Production, Other Applications), By End-Users (Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nucleic Acid Extraction Instruments And Reagents Global Market Report 2024 – By Type (Instruments, Spin Columns, Beads Or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits And Reagents And Consumables, Other Types), By Extraction Type (DNA Extraction, DNA Or RNA Extraction, RNA Extraction), By Method (Solution-Based Methods, Solid-Phase-Based Methods), By End User (Academic Research Institutes, Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Industry, Contract Research Organizations (CROs), Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nucleic Acid Labeling Global Market Report 2024 – By Product Type (Kits, Reagents, Instruments), By Labeling Type (Radioisotope Or Radioactive Labels, Non-Radioactive Labels), By Method (Enzyme-Based, Chemical-Based), By Application (DNA Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Microarrays, Blotting, In Situ Hybridization, Other Applications), By End User (Hospitals Or Clinics, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Space Militarization Global Market Report 2024 – By Type (Manned Spacecraft, Unmanned Spacecraft), By Capability (Defense, Support), By Solution (Space-Based Equipment, Space Stations, Satellites, Ground-Based Equipment, Logistics And Services) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2024 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the ribose-nucleic acid (RNA)-based therapeutics market?

The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways. For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here

How will the ribose-nucleic acid (RNA)-based therapeutics market drivers and restraints affect the ribose-nucleic acid (RNA)-based therapeutics market dynamics? What forces will shape the ribose-nucleic acid (RNA)-based therapeutics industry going forward

The ribose-nucleic acid (RNA)-based therapeutics market major growth driver - Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market. For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the ribose-nucleic acid (RNA)-based therapeutics market?

The ribose-nucleic acid (RNA)-based therapeutics market size has grown strongly in recent years. It will grow from $14.54 billion in 2023 to $15.79 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to investment and funding growth, the discovery of RNA interference (RNAi), clinical successes of antisense oligonucleotides (ASOs), regulatory support and frameworks, and collaborations, and partnerships. The ribose-nucleic acid (RNA)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to $22.30 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Major trends in the forecast period include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization and market growth. For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here

How is the ribose-nucleic acid (RNA)-based therapeutics market segmented?

The ribose-nucleic acid (RNA)-based therapeutics market is segmented
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Opthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here

Which region has the largest share of the ribose-nucleic acid (RNA)-based therapeutics market? What are the other regions covered in the report?

North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2023. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here.

Who are the major players in the ribose-nucleic acid (RNA)-based therapeutics market?

Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here.

What are the key trends in the ribose-nucleic acid (RNA)-based therapeutics market?

Major trend in the ribose-nucleic acid (RNA)-based therapeutics market - Advancements In RNA-Based Therapeutics With mRNA-Based Vaccines. For further insights on the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here.

What are the major opportunities in the ribose-nucleic acid (RNA)-based therapeutics market? What are the strategies for the ribose-nucleic acid (RNA)-based therapeutics market?

For detailed insights on the major opportunities and strategies in the ribose-nucleic acid (RNA)-based therapeutics market, request a sample here.

How does the ribose-nucleic acid (RNA)-based therapeutics market relate to the overall economy and other similar markets?

For detailed insights on ribose-nucleic acid (RNA)-based therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the ribose-nucleic acid (RNA)-based therapeutics industry?

For detailed insights on the mergers and acquisitions in the ribose-nucleic acid (RNA)-based therapeutics industry, request a sample here.

What are the key dynamics influencing the ribose-nucleic acid (RNA)-based therapeutics market growth? SWOT analysis of the ribose-nucleic acid (RNA)-based therapeutics market.

For detailed insights on the key dynamics influencing the ribose-nucleic acid (RNA)-based therapeutics market growth and SWOT analysis of the ribose-nucleic acid (RNA)-based therapeutics industry, request a sample here.